JP2022540922A5 - - Google Patents
Info
- Publication number
- JP2022540922A5 JP2022540922A5 JP2022502580A JP2022502580A JP2022540922A5 JP 2022540922 A5 JP2022540922 A5 JP 2022540922A5 JP 2022502580 A JP2022502580 A JP 2022502580A JP 2022502580 A JP2022502580 A JP 2022502580A JP 2022540922 A5 JP2022540922 A5 JP 2022540922A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- difluorophenyl
- quinoline
- radiation
- 2theta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025106721A JP2025141974A (ja) | 2019-07-17 | 2025-06-24 | ソマトスタチンモジュレーターの結晶形態 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962875285P | 2019-07-17 | 2019-07-17 | |
| US62/875,285 | 2019-07-17 | ||
| PCT/US2020/042119 WO2021011641A1 (en) | 2019-07-17 | 2020-07-15 | Crystalline forms of somatostatin modulators |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025106721A Division JP2025141974A (ja) | 2019-07-17 | 2025-06-24 | ソマトスタチンモジュレーターの結晶形態 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022540922A JP2022540922A (ja) | 2022-09-20 |
| JP2022540922A5 true JP2022540922A5 (https=) | 2023-07-10 |
Family
ID=74211310
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022502580A Pending JP2022540922A (ja) | 2019-07-17 | 2020-07-15 | ソマトスタチンモジュレーターの結晶形態 |
| JP2025106721A Pending JP2025141974A (ja) | 2019-07-17 | 2025-06-24 | ソマトスタチンモジュレーターの結晶形態 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025106721A Pending JP2025141974A (ja) | 2019-07-17 | 2025-06-24 | ソマトスタチンモジュレーターの結晶形態 |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP3999509A4 (https=) |
| JP (2) | JP2022540922A (https=) |
| WO (1) | WO2021011641A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL264178B2 (en) | 2016-07-14 | 2024-05-01 | Crinetics Pharmaceuticals Inc | Somatostatin modulators and uses thereof |
| CA3191084A1 (en) * | 2020-09-09 | 2022-03-17 | Gerald Burke | Formulations of a somatostatin modulator |
| WO2023137018A1 (en) * | 2022-01-11 | 2023-07-20 | Crinetics Pharmaceuticals, Inc. | Uses of a somatostatin modulator for the treatment of carcinoid syndrome |
| EP4547654A1 (en) | 2022-06-10 | 2025-05-07 | Assia Chemical Industries Ltd. | Solid state forms of paltusotine and process for preparation thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7563821B2 (en) * | 2005-12-05 | 2009-07-21 | Xenoport, Inc. | Levodopa prodrug mesylate, compositions thereof, and uses thereof |
| DE102011113749A1 (de) * | 2011-09-14 | 2013-03-14 | Aicuris Gmbh & Co. Kg | Sulfonsäuresalze Heterocyclylamid-substituiertr Imidazole |
| MX2019000246A (es) * | 2016-07-07 | 2019-05-27 | Plantex Ltd | Formas en estado solido del dimesilato de palbociclib. |
| IL264178B2 (en) * | 2016-07-14 | 2024-05-01 | Crinetics Pharmaceuticals Inc | Somatostatin modulators and uses thereof |
-
2020
- 2020-07-15 JP JP2022502580A patent/JP2022540922A/ja active Pending
- 2020-07-15 WO PCT/US2020/042119 patent/WO2021011641A1/en not_active Ceased
- 2020-07-15 EP EP20841603.2A patent/EP3999509A4/en active Pending
-
2025
- 2025-06-24 JP JP2025106721A patent/JP2025141974A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022540922A5 (https=) | ||
| JP5411734B2 (ja) | １−４−（５−シアノインドール−３−イル）ブチル−４−（２−カルバモイルベンゾフラン−５−イル）ピペラジン塩酸塩の多形相 | |
| JP5129132B2 (ja) | ４−メチル−ｎ−［３−（４−メチル−イミダゾル−１−イル）−５−トリフルオロメチル−フェニル］−３−（４−ピリジン−３−イル−ピリミジン−２−イルアミノ）−ベンズアミドの塩 | |
| TWI406661B (zh) | ４-甲基-ｎ-〔３-（４-甲基-咪唑-１-基）-５-三氟甲基-苯基〕-３-（４-吡啶-３-基-嘧啶-２基胺基）-苯甲醯胺之結晶型 | |
| TWI642650B (zh) | 用於製備喹啉衍生物之方法 | |
| KR101348625B1 (ko) | 이매티닙 메실레이트의 안정한 결정형 및 그의 제조방법 | |
| JP6170146B2 (ja) | チロシンキナーゼ阻害剤二マレイン酸塩のｉ型結晶およびその製造法 | |
| JP7288904B2 (ja) | ビアリールエーテル型キナゾリン誘導体 | |
| JP2010521477A (ja) | イマチニブメシレート | |
| KR101153606B1 (ko) | 아타자나비르 비술페이트 및 신규 형태의 제조 방법 | |
| CN101765595A (zh) | 制备伏立康唑的方法 | |
| JP6556293B2 (ja) | 純粋なニロチニブ及びその塩の調製のための方法 | |
| JP6985179B2 (ja) | プロリンアミド化合物の製造方法 | |
| JPWO2018117267A1 (ja) | 置換ピペリジン化合物の塩 | |
| EP1598346B1 (en) | Process for producing acid adduct salt of polyacidic base compound | |
| JP7704681B2 (ja) | センタナファジンの製造方法 | |
| TWI518072B (zh) | 塔適那偉（ａｔａｚａｎａｖｉｒ）硫酸氫鹽之製法及其新穎的形式 | |
| EP3398946B1 (en) | Salt of morpholine derivative and crystalline form thereof, as well as preparation method, pharmaceutical composition and use of the same | |
| JP2021530526A5 (https=) | ||
| WO2025002355A9 (zh) | 一种jak2抑制剂的晶型及制备方法 | |
| JPH08283262A (ja) | ４−インドリルピペラジニル誘導体 | |
| CA3011662A1 (en) | An improved process for the preparation of regorafenib | |
| JP2025541772A (ja) | ナフチリジン化合物の固体形態 | |
| WO2020119772A1 (zh) | 盐酸美呋哌瑞多晶型物及其制备方法 | |
| CA2425540A1 (en) | Crystal forms of 1-[6-chloro-5-(trifluoromethyl)-2-pyridinyl]piperazine.hydrochloride |